Collectively, these observations suggest that a variety of molecular factors, including increased PrP dosage and conformation-dependent conversion of PrP to a neurotoxic species may underlie prion disease pathology, thus providing a common pathological framework for seemingly diverse prion disease variants. This evidence concerns the gene PRNP and prion disease.